Full-Time

Customer Service Representative

Confirmed live in the last 24 hours

R1 RCM

R1 RCM

10,001+ employees

Revenue cycle management solutions for healthcare

Enterprise Software
Healthcare

Compensation Overview

$14.69 - $20.28Hourly

Entry

Jacksonville, FL, USA

The job is located in a hospital environment, which requires in-person work.

Category
Customer Support
Customer Success & Support
Required Skills
Customer Service

You match the following R1 RCM's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • High School Diploma or GED
  • Excellent customer service experience
Responsibilities
  • Working on computers and answering phones to intake information in a busy environment
  • Helping people who may be very ill or worried
  • Fast-paced work environment, often on your feet assisting patients complete their registration
  • Collecting patient and insurance information
Desired Qualifications
  • Comfortable with technology
  • Confident multi-tasker
  • Quick study with technology

R1 RCM provides Revenue Cycle Management (RCM) solutions to healthcare providers, including hospitals and physician groups. The company uses technology to streamline financial and administrative processes, helping clients reduce costs and improve patient satisfaction. R1 RCM differentiates itself by focusing on reducing administrative burdens, allowing healthcare providers to concentrate on patient care. Its goal is to enhance the financial performance and patient experience of its clients.

Company Size

10,001+

Company Stage

IPO

Total Funding

N/A

Headquarters

Murray, Utah

Founded

2003

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased telehealth adoption boosts demand for RCM solutions handling virtual care billing.
  • AI integration in RCM processes enhances automation of complex billing tasks.
  • Value-based care models create opportunities for RCM solutions aligning financial incentives with outcomes.

What critics are saying

  • Inconsistencies in service turnaround times and accuracy may affect client satisfaction.
  • Acquisition by TowerBrook and CD&R could disrupt operations and client relationships.
  • High competition in physician advisory services threatens R1 RCM's market position.

What makes R1 RCM unique

  • R1 RCM specializes in end-to-end Revenue Cycle Management for healthcare providers.
  • The company leverages advanced technology to streamline financial and administrative processes.
  • R1 RCM focuses on improving patient experience and financial performance for healthcare clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

0%

2 year growth

0%
ETF Daily News
Dec 16th, 2024
EP Wealth Advisors LLC Makes New $168,000 Investment in R1 RCM Inc. (NASDAQ:RCM)

EP Wealth Advisors LLC makes new $168,000 investment in R1 RCM Inc. (NASDAQ:RCM).

Hit Consultant
Nov 21st, 2024
Xsolis Leads In Client Satisfaction For Physician Advisory Services, Klas Report Finds

What You Should Know:– A new KLAS Research report examines the key drivers of client satisfaction in the physician advisory services market, highlighting the importance of accuracy, timeliness, strong relationships, and specialized service lines.– KLAS names Xsolis as a leader in overall client satisfaction among physician advisory services firms in helping healthcare providers navigate the complexities of regulatory and payer requirements.Key Drivers of Client SatisfactionThe report identifies several key factors that drive client satisfaction with physician advisory services:Accuracy: Providers value accurate and reliable determinations from physician advisors.Providers value accurate and reliable determinations from physician advisors. Timeliness: Prompt turnaround times for case reviews are essential for efficient workflows.Prompt turnaround times for case reviews are essential for efficient workflows. Clear Explanations: Providers appreciate clear, concise, and detailed explanations of determinations, which can be crucial for appeals if needed.Providers appreciate clear, concise, and detailed explanations of determinations, which can be crucial for appeals if needed. Strong Relationships: Building strong relationships and trust between providers and physician advisory firms is essential for effective collaboration.Report Key FindingsXsolis stands out for its high client satisfaction scores, particularly in the areas of accuracy, timeliness, and clear explanations. Clients praise the expertise of Xsolis’ physician advisors and the comprehensive documentation provided.The report also examines other leading physician advisory services firms, including R1 RCM, Brundage Medical Group, and Sound Physicians. Each firm has its own strengths and areas for improvement, highlighting the diverse landscape of this market.R1 RCM: Clients appreciate the comprehensive documentation and summaries provided by R1 RCM, but some report inconsistencies in turnaround times and accuracy, potentially due to high case volumes.Brundage Medical Group: Clients value the firm’s quick response rates and comprehensive explanations, which have led to positive outcomes like increased payer payments and improved CMS Star ratings

Stock Titan
Nov 19th, 2024
R1 RCM $8.9B Buyout, CEO Returns

R1 RCM has been acquired by TowerBrook Capital Partners and Clayton, Dubilier & Rice in a deal valued at approximately $8.9 billion. The acquisition, announced on August 1, 2024, involved purchasing all outstanding shares at $14.30 per share in cash. Following the transaction, R1 RCM is now a private company and has ceased trading on Nasdaq. Joe Flanagan has returned as CEO, replacing Lee Rivas, to focus on operational excellence and technology leadership.

Hit Consultant
Oct 16th, 2024
Hlth 2024: 21 Executives Share Their Predictions And Insights

As HLTH 2024 prepares to convene in Las Vegas, the anticipation for groundbreaking insights and transformative discussions is palpable. To get a glimpse into the key themes and predictions shaping this year’s event, we reached out to 21 digital health executives for their expert perspectives.From the rise of generative AI and the evolving role of virtual care to the increasing focus on health equity and value-based care, these industry leaders offer a diverse range of perspectives on the most pressing challenges and promising opportunities facing the healthcare ecosystem.Join us as we delve into their predictions and explore the trends that are poised to redefine the future of healthcare at HLTH 2024.Ryne Natzke, chief revenue officer, TrustCommerce, a Sphere company, a provider of end-to-end integrated healthcare payments and security softwareAI, AI, and more AI! I’m looking forward to seeing how AI is being applied to help clinicians, patients, and other staff members provide better patient experiences and outcomes. Everything is moving so quickly that it will be exciting to get an update on where the industry is going.James Aita, director, Strategy and Business Development, Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutionsOf course AI is the hot topic at HLTH this year–but with the new regulations from ASTP/ONC, the question is how can it be usable, trustworthy, transparent and helpful. I’m also interested in seeing who else is making AI and clinical data helpful at the point of care to reduce the burden on clinicians and inform patient care.Lyle Berkowitz, MD, CEO, KeyCare, the nation’s first Epic-based virtual care companyI always look forward to HLTH and seeing presentations of the newest cutting-edge technology and ideas. This year, I’m expecting deeper and wider use cases of AI to lead the charge. But in addition to technology innovations, I’m also hoping we will hear about other people and process topics such as how to set up virtual care teams and how to rethink primary care physician compensation to better align around adoption of automation and team-based care.Kazu Okuda, MD, CEO and co-founder of Universal Brain, whose platforms use brain-function measurement to drive precision psychiatryThe emergence of personalized treatment is an exciting field that I expect to take center stage at HLTH this year

MarketBeat
Sep 23rd, 2024
Davidson Kempner Capital Management LP Invests $6.53 Million in R1 RCM Inc. (NASDAQ:RCM)

Davidson Kempner Capital Management LP invests $6.53 million in R1 RCM Inc. (NASDAQ:RCM).

EIN News
Aug 26th, 2024
Revenue Cycle Management Market to Surge to $367.7 Billion by 2031 As Revealed In New Report

For instance, R1 RCM Inc launched R1 Professional in January 2020, an advanced RCM solution that is widely used by large hospital-owned medical groups and other groups involved in independent practices.

36Kr
Aug 17th, 2024
R1 RCM Sold for $8.9 Billion

R1 RCM, a major player in the U.S. healthcare revenue cycle management sector, announced its acquisition and privatization for $8.9 billion in early August. This follows Waystar's $1 billion IPO in June. R1's main shareholders, TCP-ASC and New Mountain Capital, initially vied for control, but TowerBrook Capital Partners and CD&R's superior offer of $14.3 per share prevailed. R1's stock rose from $11.1 to around $14. This marks R1's second acquisition and delisting.

GlobeNewswire
Aug 1st, 2024
R1 Rcm To Be Acquired By Towerbrook And Cd&R For $8.9 Billion

MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (“CD&R”), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company’s outstanding shares of common stock, including the warrant held by TowerBrook. Under the terms of the agreement, TowerBrook and CD&R will acquire all the outstanding common stock that TowerBrook does not currently own for $14.30 per share.The consideration of $14.30 per share in common stock to R1 stockholders represents a premium of approximately 29% to the Company’s unaffected closing price on February 23, 2024, the last full trading day before New Mountain Capital publicly disclosed its initial non-binding acquisition proposal on its Schedule 13D.The transaction has been unanimously approved by a special committee of the R1 Board of Directors comprised solely of independent directors (the “Special Committee”), which, as previously announced on March 11, 2024, was formed to evaluate strategic alternatives. Transaction negotiations were led by the Special Committee, advised by independent legal and financial advisors, and following the recommendation of the Special Committee, R1’s Board approved the transaction.“TowerBrook has been an outstanding long-term investor and partner to R1 and shares our vision of being the automation platform of choice for the provider industry,” said Lee Rivas, R1’s CEO

Financial Post
Aug 1st, 2024
RBC, Deutsche Bank plan US$4.5-billion debt sale for R1 RCM

Deutsche Bank and Royal Bank of Canada are preparing a US$4.5 billion debt package to help fund TowerBrook Capital and Clayton Dubilier & Rice's planned purchase of R1 RCM Inc., according to people familiar with the matter.